Advertisement

Hemorrhagic Complications in Cutaneous Surgery

  • Hugh M. GlosterJr.

Abstract

It is logical to assume that anyone who performs cutaneous surgery has had or will have some sort of hemorrhagic complication, an inevitable event even in the hands of the most careful and skilled surgeon. Therefore, it is important for cutaneous surgeons to not only take precautions to prevent bleeding complications before they occur, but also to be capable of diagnosing and managing these unfortunate events as they arise to provide a better service for patients. This article will focus on the prevention, diagnosis, and management of hemorrhagic complications in cutaneous surgery.

Keywords

Warfarin Therapy Hemorrhagic Complication Herbal Supplement Cutaneous Surgery Persistent Bleeding 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Salasche S. Acute surgical complications: cause, prevention, and treatment. J Am Acad Dermatol 1986;15:1163–1185.CrossRefPubMedGoogle Scholar
  2. 2.
    Salasche S, Grabski W. Complications of flaps. J Dermatol Surg Oncol 1991;17:132–140.PubMedGoogle Scholar
  3. 3.
    Alam M, Goldberg L. Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy. Dermatol Surg 2002;28:992–998.CrossRefPubMedGoogle Scholar
  4. 4.
    Antman E. The re-emergence of anticoagulation in coronary disease. Eur Heart J Suppl 2004;6:B2–B8.CrossRefGoogle Scholar
  5. 5.
    Amann R, Peskar B. Anti-inflammatory effects of aspirin and sodium salicylate. Eur J Pharmocol 2002;447:1–9.CrossRefGoogle Scholar
  6. 6.
    Flower R, Moncada S, Vane J. Analgesic-antipyretics and anti-inflammatory agents: drugs employed in the treatment of gout. In: Goodman LS, Gilman AG, eds. The pharmacological basis of therapeutics. 7th ed. New York: MacMillan; 1985:690–704.Google Scholar
  7. 7.
    Chang L, Whitaker D. The impact of herbal medicines on dermatologic surgery. Dermatol Surg 2001;27:759–763.CrossRefPubMedGoogle Scholar
  8. 8.
    Weisberg N, Becker D. Potential role of the new specific COX-2 inhibitors in dermatologic surgery. Dermatol Surg 2000;26:551–553.CrossRefPubMedGoogle Scholar
  9. 9.
    CAPRIE Steering Committee. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329–1339.CrossRefGoogle Scholar
  10. 10.
    Barnett H, Eliasziw M, Meldrum H. Drugs and surgery in the prevention of ischemic stroke. N Engl J Med 1995;332:238–248.CrossRefPubMedGoogle Scholar
  11. 11.
    Desager J. Clinical pharmacokinetics of ticlopidine. Clin Pharmocokinet 1994;26:347–355.CrossRefGoogle Scholar
  12. 12.
    Moake J, Funicella T. Common bleeding problems. Clin Symp 1983;35:1–32.PubMedGoogle Scholar
  13. 13.
    Sharis P, Cannon C, Loscalzo J. The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med 1998;129:394–405.PubMedGoogle Scholar
  14. 14.
    Samlaska C, Winfield E. Pentoxifylline. J Am Acad Dermatol 1994;30:603–621.CrossRefPubMedGoogle Scholar
  15. 15.
    Chiquette E, Amato M, Bussey H. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998;158:1641–1647.CrossRefPubMedGoogle Scholar
  16. 16.
    Mohr J. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001;345:1444–1451.CrossRefPubMedGoogle Scholar
  17. 17.
    Bauer K. Selective inhibition of coagulation factors: advances in antithrombotic therapy. Semin Thromb Hemost 2002;28:15–24.CrossRefPubMedGoogle Scholar
  18. 18.
    Majerus P, Broze G, Miletich J, Tollefsen D. Anticoagulant thrombolytic, and antiplatelet drugs. In: Hardman JG, Limbird LE, eds. Goodman and Gilman’s the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill; 1996:1347–1351.Google Scholar
  19. 19.
    Horton J, Bushwick B. Warfarin therapy: evolving strategies in anticoagulation. Am Fam Physician 1999;59:1–19.Google Scholar
  20. 20.
    Goldsmith S, Leshin B, Owen J. Management of patients taking anticoagulants and platelet inhibitors prior to dermatologic surgery. J Dermatol Surg Oncol 1993;19:578–581.PubMedGoogle Scholar
  21. 21.
    Lawrence C, Sakuntabhai A, Tiling-Grosse S. Effect of aspirin and nonsteroidal anti-inflammatory drug therapy on bleeding complications in dermatologic surgical patients. J Am Acad Dermatol 1994;31:988–992.CrossRefPubMedGoogle Scholar
  22. 22.
    Otley C, Fewkes J, Frank W, Olbricht S. Complications of cutaneous surgery in patients who are taking warfarin, aspirin, and nonsteroidal anti-inflammatory drugs. Arch Dermatol 1996;132:161–166.CrossRefPubMedGoogle Scholar
  23. 23.
    Billingsley E, Maloney M. Intraoperative and postoperative bleeding problems in patients taking warfarin, aspirin, and nonsteroidal anti-inflammatory agents. Dermatol Surg 1997;23:381–385.CrossRefPubMedGoogle Scholar
  24. 24.
    Bartlett G. Does aspirin affect the outcome of minor cutaneous surgery? Br J Plast Surg 1999;52:214–216.CrossRefPubMedGoogle Scholar
  25. 25.
    Alcalay J. Cutaneous surgery in patients receiving warfarin therapy. Dermatol Surg 2001;27:756–758.CrossRefPubMedGoogle Scholar
  26. 26.
    Kargi E, Babuccu O, Hosnuter M, Babuccu B, Altinyazar C. Complications of minor cutaneous surgery in patients under anticoagulant therapy. Aesthetic Plast Surg 2002;26:483–485.CrossRefPubMedGoogle Scholar
  27. 27.
    Ah-Weng A, Natarajan S, Velangi S, Langtry J. Preoperative monitoring of warfarin in cutaneous surgery. Br J Dermatol 2003;149:386–389.CrossRefPubMedGoogle Scholar
  28. 28.
    Syed S, Adams B, Liao W, Pipitone M, Gloster H. A prospective assessment of bleeding and INR in warfarin-anticoagulated patients having cutaneous surgery. J Am Acad Dermatol 2004;51:955–957.CrossRefPubMedGoogle Scholar
  29. 29.
    Kovich O, Otley C. Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation. J Am Acad Dermatol 2003;48:233–237.CrossRefPubMedGoogle Scholar
  30. 30.
    Schanbacher CF, Bennett R. Postoperative stroke after stopping warfarin for cutaneous surgery. Dermatol Surg 2000;26:785–789.CrossRefPubMedGoogle Scholar
  31. 31.
    Ferraris V, Swanson E. Aspirin usage and perioperative blood loss in patients undergoing unexpected operations. Surg Gynecol Obstet 1983;156:439–442.PubMedGoogle Scholar
  32. 32.
    Madura J, Rookstool M, Wease G. The management of patients on chronic coumadin therapy undergoing subsequent surgical procedures. Am Surg 1194;60;542–546.Google Scholar
  33. 33.
    Amrein P, Ellman L, Harris W. Aspirin-induced prolongation of bleeding time and perioperative blood loss. JAMA 1981;245:1825–1828.CrossRefPubMedGoogle Scholar
  34. 34.
    Hall D, Steen W, Drummond J. Anticoagulants and cataract surgery. Ophthalmic Surg 1988;19:221–222.PubMedGoogle Scholar
  35. 35.
    Hunter G, Barney M, Crapo R. Perioperative warfarin therapy in combined abdominal lipectomy and intraabdominal gynecological surgical procedures. Ann Plast Surg 1990;25;37–41.CrossRefPubMedGoogle Scholar
  36. 36.
    Hirsh J, Dalen J, Anderson DR. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1998;114:444S–469S.CrossRefGoogle Scholar
  37. 37.
    Fader D, Johnson T. Medical issues and emergencies in the dermatology office. J Am Acad Dermatol 1997;36:1–16.CrossRefPubMedGoogle Scholar
  38. 38.
    Kimyai-Asadi A, Jih M, Goldberg L. Perioperative primary stroke: is aspirin cessation to blame? Dermatol Surg 2004;30:1526–1529.CrossRefPubMedGoogle Scholar
  39. 39.
    Houry S, Georgeac C, Hay JM. A prospective multicenter evaluation of preoperative hemostatic screening tests. The French Association for Surgical Research. Am J Surg 1995;170:19.CrossRefPubMedGoogle Scholar
  40. 40.
    Collins S, Dufresne R. Dietary supplements in the setting of Mohs surgery. Dermatol Surg 2002;28:447–452.CrossRefPubMedGoogle Scholar
  41. 41.
    Norred C, Zamudio S, Palmer S. Use of complementary and alternative medicines by surgical patients. ANNA J 2000;68:13–18.Google Scholar
  42. 42.
    Peterson S, Joseph A. Inherited bleeding disorders in dermatologic surgery. Dermatol Surg 2001;27:885–889.CrossRefPubMedGoogle Scholar
  43. 43.
    Werner E. Von Willebrand disease in children and adolescents. Pediatr Clin North Am 1996;43:683–707.CrossRefPubMedGoogle Scholar
  44. 44.
    Kasper C, Boylen L, Ewing N, Luck J, Dietrich S. Hematologic management of hemophilia A for surgery. JAMA 1985;253:1279–1283.CrossRefPubMedGoogle Scholar
  45. 45.
    Mulliken J, Healey N. Pathogenesis of skin flap necrosis from an underlying hematoma. Plast Reconstr Surg 1979;63:540–545.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Hugh M. GlosterJr.
    • 1
  1. 1.Department of DermatologyUniversity of CincinnatiCincinnatiUSA

Personalised recommendations